business

Evercore ISI raises BridgeBio Pharma price target on Attruby sales

Investing.com · May 8, 2026, 9:53 AM · Also reported by 4 other sources

Read full story on Investing.com → More top stories

Also covered by

Yahoo Finance Rosenblatt resets Palantir stock price target after earnings Yahoo Finance The Middleby Sees Strong Q1 Sales, Raises 2026 Outlook The Verge Sony’s PS5 sales plummet amid price rises and a memory crisis Bloomberg Markets Novo Nordisk’s Ozempic India Price Cut Boosts Obesity Drug Sales

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Evercore ISI raises BridgeBio Pharma price target on Attruby sales

Also covered by

More in business